Diabetes & CV Disease
Sort by:
Omnipod®
Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D
FEATURING
Francisco Pasquel
- 106 views
- September 12, 2024
- 2
Omnipod®
Unlock the Future of Type 2 Diabetes Care (featuring Dr. Viral Shah)
FEATURING
Viral Shah
- 171 views
- September 12, 2024
Peter Nilsson
Recent Diabetes CVD Trials on SGLT2 and GLP1 and their Effects on Body Weight and Hypertension
- 179 views
- September 16, 2024
- 1
Bijin Thajudeen
Management of Kidney Health in CKD and DKD: A Cased-Based Approach
- 147 views
- September 16, 2024
- 1
Bijin Thajudeen
Management of Kidney Health in CKD and DKD: A Cased-Based Multiple-choice Assessment
- 100 views
- September 16, 2024
- 2
AdventHealth
FLOW: The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor Agonist
FEATURING
Richard Pratley
- 917 views
- September 17, 2024
- 9
MUSC Cardiology
Update on GLP1 RA and SGLT2 Inhibitors in HFpEF
FEATURING
Mikhail Kosiborod
- 1,019 views
- October 3, 2024
- 4
MUSC Cardiology
Controlling Blood Pressure in the Patient with HFpEF
FEATURING
Jan Basile
- 1,021 views
- October 3, 2024
- 13
Ezekiel Emanuel
Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists
- 151 views
- October 3, 2024
- 1
MUSC Cardiology
Practical Tips for Managing Challenging, Real-World HFpEF Patients
- 117 views
- October 4, 2024
- 1
Heart in Diabetes (HiD)
Hypertension Awakenings: Finally Something New to Talk About
FEATURING
Raymond R. Townsend
- 1,247 views
- October 7, 2024
- 10
Heart in Diabetes (HiD)
GLP1-RA and Risk of Stroke
FEATURING
Lawrance A. Leiter
- 57 views
- October 7, 2024
- 1
UChicago Medicine
SGLT2 Inhibitors: Drugs for the Ages
FEATURING
Ralph DeFronzo
- 628 views
- October 11, 2024
- 7
Rosa Drummond
Glucagon-Like Peptide Receptor Agonist Use in Pregnancy: A Review
- 719 views
- October 11, 2024
- 3
Jennifer Rosselli
Switch, Change, Rearrange: Diabetes Medication Transitions, De-prescribing, and Strategic Switching
FEATURING
Sydnie Twillmann
- 202 views
- October 11, 2024
- 5
James O'Keefe
GLP’s Are Anti-Consumption and Longevity Agents and SGLT-i’s Slow Aging and Improve Lifespan
- 14 views
- October 17, 2024
28th Annual Heart Failure 2024: An Update on Therapy
SGLT2 Inhibition in 2024: Use in Heart Failure and Mechanism of Action
FEATURING
Milton Packer
- 50 views
- October 17, 2024
- 1
Robert Dubin
Glucagon-like Peptide-1 Receptor Agonist-Based Agents and Weight Loss Composition: Filling the Gaps
- 178 views
- October 21, 2024
- 1
Keck School of Medicine of USC
Strategies for Renal Protection in Diabetic Kidney Disease
FEATURING
Christine Limonte
- 16 views
- October 21, 2024